November 3, 2023
Pharmac committee recommends continued funding of food thickeners for people with MND
Today, Pharmac has published the minutes of the August PTAC (Pharmacology and Therapeutics Advisory Committee) meeting, where…
Advocacy Articles
1 - 12 of 77 posts
Advocacy, Clinical News
Advocacy, Clinical News
October 31, 2023
Medsafe confirms error with changes to Riluzole
Late last week we were advised Medsafe had updated the prescribing regime for Riluzole, a drug that…
Advocacy, Clinical News
October 27, 2023
Update on recent Riluzole prescribing changes
Motor Neurone Disease NZ has been made aware of a change Medsafe has recently made to the…
Advocacy, Clinical News
February 22, 2023
Pharmac proposal to phase out funding of food thickeners
MND NZ is extremely disappointed with Pharmac’s proposal to phase out funding of food thickeners for…
Advocacy, Clinical News
June 18, 2020
Motor Neurone Disease Clinical Working Group aims to improve lives through standardised care
Last September, we held the first-ever MND Hui at Parliament. The hui offered the chance for people…
Advocacy
October 16, 2019
MND Community Survey Findings announced
We’re proud to share the findings of our MND Community Survey, and appreciate the time and effort…
Advocacy, Treatments
October 2, 2019
Outcome of consultation on the changes to the prescribing restrictions of riluzole
We have been closely following the Medsafe consultation on the changes to the prescribing restrictions of riluzole…